承認 against Fu Shi Rebio K.K.

富士レビオ株式会社 (医薬品医療機器等法)
医薬品医療機器等法Ministry of Health, Labour and WelfareDecember 5, 2022

Action summary

Company
Original: 富士レビオ株式会社
Governing law
医薬品医療機器等法
医薬品医療機器等法
Action type
承認
承認
Action date
December 5, 2022
Issuing authority
Ministry of Health, Labour and Welfare
厚生労働省

Violation

Machine-translated summary — verify against original

First approval of a general-use test reagent for simultaneous testing of the novel coronavirus and influenza.

Show original Japanese text

新型コロナウイルス・インフルエンザを同時に検査する一般用検査薬として初めての承認

Source

Original Ministry of Health, Labour and Welfare announcement (in Japanese)

The original Japanese disclosure is the authoritative record.

Watch this company

Get an email when Fu Shi Rebio K.K. has new enforcement actions or registry changes (representative, address, business status). Sign-in is via a one-time email link — no password.

Company info

English name
Fu Shi Rebio K.K. Romanized
Japanese name
富士レビオ株式会社
See company profile →

About this recordAggregated and translated from public Japanese government disclosures. The English text is for reference only — authoritative content is the linked Japanese source.